For individuals with high blood pressure or diabetes, regular health check-ups are essential for early detection of kidney problems.

Diabetes is one of the leading causes of kidney failure. It damages the kidneys through a slow, progressive process that primarily targets the organs' delicate filtering systems.

On March 10, 2026, the team led by Dr. An Chiying at Shenzhen Hengsheng Hospital, affiliated with Shanghai Fosun Health, ...

Chronic kidney disease (CKD) is a growing global health concern, yet it often goes unnoticed until advanced stages, limiting opportunities for early intervention. This is why World Kidney Day is a ...

XORTX Therapeutics Inc. ("XORTX " or the “Company ”) (NASDAQ: XRTX \| TSXV: XRTX \| Frankfurt: ANU), a late stage clinical p ...

Obesity is a serious health issue that increases the risk of developing diabetes and increases the risk of diabetic kidney ...

Diabetes is one of the leading causes of kidney disease worldwide, and India carries a particularly high burden of both conditions. What makes diabetic kidney disease especially concerning is that it ...

Vote well in advance of the proxy voting deadline: March 20, 2026; XORTX’s board of directors unanimously recommends that Shareholders vote FOR all re ...

Bayer announces finerenone meets primary endpoint in pivotal phase III FIND-CKD study in patients with non-diabetic chronic kidney disease: Berlin Tuesday, March 17, 2026, 15:00 H ...

The world is experiencing a hidden epidemic with kidney disease. More than 850 million people worldwide have some form of ...

The Phase III study FIND-CKD ( NCT05047263) — investigating the efficacy and safety of KERENDIA ® (finerenone) versus placebo when added to standard of care in adult patients with non-diabetic chronic ...

Kerendia has hit the spot in another phase 3 trial that could extend its use as a treatment for patients with chronic kidney disease (CKD). Extending the label for Kerendia is a strategic priority for ...